Community Blood Supply Model: Development of a New Model to Assess the Safety, Sufficiency, and Cost of the Blood Supply

Brian Custer, Eric S. Johnson, Sean D. Sullivan, Tom K. Hazlet, Scott D. Ramsey, Edward L. Murphy and Michael P. Busch
Additional contact information
Brian Custer: Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118-4417; Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle; Blood Systems Research Institute, San Francisco, Californiabcuster@bloodsystems.org.
Scott D. Ramsey: Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle
Michael P. Busch: Blood Systems Research Institute, San Francisco, California; and University of California, San Francisco, Department of Laboratory Medicine

Medical Decision Making, 2005, vol. 25, issue 5, 571-582

Abstract: Background. Through a combination of predonation donor screening and donated unit testing, the blood supply is safer than ever. However, as a result of increasingly stringent screening measures, one of the greatest threats may be an insufficient supply. The balance between safety and adequacy of the blood supply has not received enough attention. Study Design and Methods. The authors developed a model to allow for empirical investigation of the determinants of a safe and sufficient supply. The model is a cohort simulation of allogeneic whole-blood donation, with the population of presenting donors stratified into 8 age and gender groups because the probability of donor and donation deferral varies by these characteristics. Parameters are estimated from year 2000 Blood Centers of Pacific (BCP) data. The model includes cost parameters, which were estimated using BCP expenditure data. The main outcomes are the number of transfusable units of blood and the unit cost of procurement. Results. The model tracks the production of a supply of blood, highlighting the influence of demographic characteristics, predonation deferral, underweight collection of blood units, and associated costs. The authors sought to establish model validity by showing that modeled results closely mimic the outcomes and costs observed by blood bank administrators. Conclusion. The model was developed to evaluate blood safety and policy decisions; it can be used to assess the impact of predonation deferrals, such as expanded European travel deferral for variant Creutzfeldt-Jakob disease, or the impact of new testing strategies, such as nucleic acid testing for West Nile virus.

Keywords: blood donors; blood banks; cohort; computer simulation; costs and cost analysis; economics (search for similar items in EconPapers)
Date: 2005
References: View complete reference list from CitEc
Citations: View citations in EconPapers (7)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X05280557 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:25:y:2005:i:5:p:571-582

DOI: 10.1177/0272989X05280557

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().